The way I read it, the trial is for the actual health workers to take the drug themselves and see if that prevents acquiring the virus in a statistically significant manner. If that works it keeps for providers online. Also we could see people both asymptomatic and virus clear, taking it to prevent new cases. Other folks are looking at it as treatment for active cases.
These are already drugs on the market. This is just an ‘off-label’ prescription. No need for phase I, safety and side effects already known. Will be interesting to see.
These are already drugs on the market. This is just an off-label prescription. No need for phase I, safety and side effects already known. Will be interesting to see."
_____________
.... thank you